Abstract: An improved method of producing 3-amino-1,2,4-benzotriazines using nitrobenzene or a derivative thereof, a guanidine salt and a base as reactants is provided. The method is carried out at a moderate reaction temperature without producing halide wastes derived from nucleophilic substitution and acid byproducts.
Abstract: The present invention provides a micro-robot for use inside the body during minimally-invasive surgery. The micro-robot includes an imaging devices, a manipulator, and in some embodiments a sensor.
Type:
Grant
Filed:
January 24, 2006
Date of Patent:
October 24, 2006
Assignee:
Board of Regents of the University of Nebraska
Inventors:
Shane Farritor, Dmitry Oleynikov, Stephen R. Platt, Mark Rentschler, Jason Dumpert
Abstract: This invention relates to the field of therapy and diagnostic methods for ulcerative colitis. Specifically, the method comprises administering a compound or recombinant protein that inhibits interaction between CEP and human tropomyosin. Also included in the invention are methods to screen for drugs useful in treating ulcerative colitis and diagnostic methods for detecting diseases associated with an autoantigen response to hTM in affected tissue.
Type:
Grant
Filed:
February 5, 2003
Date of Patent:
October 17, 2006
Assignee:
University of Medicine & Dentistry of New Jersey
Abstract: Methods and kits for identifying RNAs and DNAs associated with an RNA or DNA binding protein via a detector specific for the binding protein or protein bound thereto which is linked to an oligonucleotide capable of directing the synthesis of cDNA copies of RNA or DNA that are in close proximity to or in the vicinity of the bound detector are provided.
Type:
Grant
Filed:
August 17, 2001
Date of Patent:
October 17, 2006
Assignee:
Trustees of the University of Pennsylvania
Abstract: The present invention establishes the fact that the degradation of SP to SP(1-4) by endogenous NEP in BM stroma can be a mediator of hematopoietic stimulation by stem cell factor (SCF) and induce the production of TGF-? and TNF-? in BM stroma. The present invention establishes that compositions containing the SP(1-4) polypeptide, or NEP genetic elements, can be used to slow and or stop the rapid growth of stem and progenitor cells thus protecting them from the deleterious effects of cancer therapy. Hence, the polynucleotides and proteins of the present invention may be used to protect stem cells from the toxic effects of chemo- and radio-therapy, in those undergoing, or about to undergo such cancer related treatments. Also provided are compositions containing NEP antisense sequences and antibodies used for the increased proliferation and differentiation of stem and/or progenitor cells in those whom have already undergone chemo- and/or radio-therapy.
Type:
Grant
Filed:
May 21, 2002
Date of Patent:
October 10, 2006
Assignee:
University of Medicine and Dentistry of New Jersey
Abstract: Methods, systems and kits are provided for detecting and quantifying multiple immunogens in a sample via consecutive addition of quantifiable extenders to immunogen bound complexes of immunogen binding agent attached to a DNA containing an RNA polymerase promoter.
Type:
Grant
Filed:
August 14, 2002
Date of Patent:
October 3, 2006
Assignee:
Trustees of the University of Pennsylvania
Abstract: Disclosed are various genes encoding proteins that are shown to play a role, direct or indirect, in microbial resistance of an organism in a biofilm and homologs thereof. Also disclosed are methods of identifying a compound that modulates microbial resistance of an organism in a biofilm, and methods of identifying genes that encode proteins that play a role, direct or indirect, in biofilm resistance.
Abstract: Compositions containing cyclophilin B, mutants of cyclophilin B or inhibitors of cyclophilin B and methods of using these compositions to modulate somatolactogenic function are provided.
Type:
Grant
Filed:
August 10, 2000
Date of Patent:
September 12, 2006
Assignee:
Trustees of the University of Pennsylvania
Abstract: Fused-ring triazole compounds which inhibit proliferation of cells and exhibit a unique and intense fluorescence are provided. Also provided are methods for synthesizing these compounds and methods for using these compounds to inhibit cell proliferation and infection and to label and fluorescently detect selected molecules.
Type:
Grant
Filed:
August 19, 2004
Date of Patent:
September 12, 2006
Assignees:
University of Medicine and Dentistry of New Jersey, Rutgers, the State University, Lehigh University
Inventors:
Jeffrey D. Laskin, Ned Heindel, Diane Heck, Anna Marie Vetrano, Christophe Guillon, Peter DeMatteo
Abstract: Methods and kits are provided for manipulating and predicting the reproductive capacity of a female subject. The presence of endogenous neurotrophins and addition of exogenous neurotrophins, particularly BDNF, NT-4/5, and NGF, increase the reproductive capacity of a female patient by binding to receptors on the oocytes and stimulating maturation of the oocytes. Administration of antagonists act as a contraceptive because the antagonists prevent the neurotrophins from binding to oocyte receptors. Neurotrophins may also be used to stimulate the maturation of oocyte in vitro.
Type:
Grant
Filed:
July 31, 2002
Date of Patent:
August 29, 2006
Assignee:
University of Medicine and Dentistry of New Jersey
Inventors:
David B Seifer, Robert Shelden, Bo Feng, Cheryl Dreyfus
Abstract: The present invention relates to methods of identifying agents which modulate the activity of PIPKI?661. Methods of using such agents to prevent or treat a cell migration-mediated condition or disease in a subject are also provided.
Type:
Grant
Filed:
June 25, 2003
Date of Patent:
August 29, 2006
Assignee:
Wisconsin Alumni Research Foundation
Inventors:
Richard A. Anderson, Kun Ling, Renee L. Doughman
Abstract: Provided in a phosphate ion adsorbent containing a weakly basic anion exchange resin as an active ingredient which aims at providing preventives and/or remedies for hyperphosphatemia having a high selectivity for the adsorption of phosphate ion and showing an effect of lowering blood phosphorus level and another effect of suppressing phosphorus excretion into the urine.
Abstract: A post-CMP washing liquid composition is provided which includes one type or two or more types of aliphatic polycarboxylic acids and one type or two or more types selected from the group consisting of glyoxylic acid, ascorbic acid, glucose, fructose, lactose, and mannose, and which has a pH of less than 3.0. This washing liquid has excellent performance in removing micro particles and metal impurities adhering to the surface of a semiconductor substrate after CMP and does not corrode a metal wiring material.
Type:
Grant
Filed:
May 9, 2003
Date of Patent:
August 8, 2006
Assignees:
Kanto Kagaku Kabushiki Kaisha, NEC Electronics Corporation
Abstract: The present invention discloses a seven amino acid peptide (7AA) of bombesin. Methods for reducing the impairment respiratory tract mucosal immunity, reducing the rate of infection of the respiratory tract by pathogenic microorganisms and reducing the atrophy or dysfunction of the GALT comprising administering an effective amount of 7AA are also provided.
Abstract: A patch comprising a backing layer and a adhesive layer formed on the back face of the backing layer wherein a woven fabric or a nonwoven fabric made of a rayon and pulp fiber mixture is employed as the backing layer and the mixing ratio thereof is from 3:7 to 7:3. When employed in taping a finger, a wrist, an ankle, neck, an elbow, a knee or the like, the patch would not soon curl up or peel off at an overlapping part. After the patch is adhered and then stripped off, no fiber piece remains on the pressure-sensitive adhesive face of the backing layer so that the adhesive force of the patch can be sustained in the case of re-adhesion.
Type:
Grant
Filed:
October 3, 2003
Date of Patent:
June 20, 2006
Assignee:
Hisamitsu Pharmaceuticals Co., Inc.
Inventors:
Kazunori Muta, Yasuhisa Kose, Masatoshi Kita
Abstract: A method and composition for treatment of advanced cutaneous T cell lymphoma is provided which involves administration of recombinant interleukin-12.
Type:
Grant
Filed:
October 15, 1999
Date of Patent:
May 30, 2006
Assignee:
Trustees of the University of Pennsylvania
Abstract: The enzyme Lp-PLA2 in purified form, an isolated nucleic acid molecule encoding Lp-PLA2, the use of an inhibitor of the enzyme Lp-PLA2 in therapy and a method of screening compunds to identify those compounds.
Abstract: The present invention provides cDNAs encoding deoxyribonuclease II? and isolated, purified deoxyribonuclease II? proteins. Antibodies against this protein and antisense agents targeted to a cDNA or corresponding mRNA encoding deoxyribonuclease II? are provided. In addition, methods of identifying and using modulators of deoxyribonuclease II? activity are described.
Type:
Grant
Filed:
March 1, 2004
Date of Patent:
May 23, 2006
Assignee:
Trustees of Dartmouth College
Inventors:
Alan Richard Eastman, Ronald J. Krieser
Abstract: The present invention provides a high-throughput screening assay to identify test agents as cholesterol inhibitors via mutant NCP1 mammalian cells. Also provided are cholesterol inhibiting agents identified in accordance with this assay and methods for using such agents to inhibit cholesterol accumulation in cells.